Items where authors include "Low, A."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Low, A., McKiernan, E., Prats-Sedano, M.A. et al. (41 more authors) (2024) Neuroimaging and clinical findings in healthy middle-aged adults with mild traumatic brain injury in the PREVENT dementia study. JAMA Network Open, 7 (8). e2426774. ISSN 2574-3805
Ritchie, C.W. orcid.org/0000-0002-6202-6906, Bridgeman, K. orcid.org/0000-0002-4168-1493, Gregory, S. orcid.org/0000-0001-9864-8240 et al. (20 more authors) (2024) The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia. Brain Communications, 6 (3). fcae189. ISSN 2632-1297
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Mak, E. orcid.org/0000-0002-6437-8024, Dounavi, M.-E. orcid.org/0000-0001-8287-346X, Operto, G. et al. (84 more authors) (2024) APOE ɛ4 exacerbates age-dependent deficits in cortical microstructure. Brain Communications, 6 (1). fcad351. ISSN 2632-1297
Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723
Curry, P.D.K. orcid.org/0000-0003-0013-460X, Morris, A.P. orcid.org/0000-0002-6805-6014, Jani, M. orcid.org/0000-0002-1487-277X et al. (133 more authors) (2024) Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response. Rheumatology Advances in Practice, 8 (1). rkae014. ISSN 2514-1775
Borchert, R.J. orcid.org/0000-0002-4673-9746, Azevedo, T. orcid.org/0000-0002-2052-3832, Badhwar, A. orcid.org/0000-0003-3414-3395 et al. (29 more authors) (2023) Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: a systematic review. Alzheimer's & Dementia, 19 (12). pp. 5885-5904. ISSN 1552-5260
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Dounavi, M.-E. orcid.org/0000-0001-8287-346X, Mak, E., Swann, P. et al. (15 more authors) (2023) Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife. Journal of Cerebral Blood Flow & Metabolism, 43 (10). pp. 1672-1684. ISSN 0271-678X
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Low, A., Prats-Sedano, M.A., McKiernan, E. et al. (15 more authors) (2022) Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study. Alzheimer’s Research & Therapy, 14 (1). 154. ISSN 1758-9193
Dounavi, M.-E., Newton, C., Jenkins, N. et al. (13 more authors) (2022) Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia : the PREVENT-Dementia study. Journal of Neurology, 269. pp. 4299-4309. ISSN 0340-5354
Low, A., Parry-Okeden, S., Ferguson, E.C. et al. (2 more authors) (2022) Fifteen-minute consultation : the child with obesity. Archives of Disease in Childhood: Education & Practice, 107 (3). pp. 182-187. ISSN 1743-0585
Dounavi, M.-E., Low, A., Muniz-Terrera, G. et al. (5 more authors) (2022) Fluid-attenuated inversion recovery magnetic resonance imaging textural features as sensitive markers of white matter damage in midlife adults. Brain Communications, 4 (3). fcac116. ISSN 2632-1297
Low, A., Prats-Sedano, M.A., Stefaniak, J.D. et al. (11 more authors) (2022) CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults : the PREVENT-Dementia study. Journal of Neurology, Neurosurgery & Psychiatry, 93 (5). pp. 481-490. ISSN 0022-3050
Up a level